What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now?

Core Insights - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] - ChromaDex (CDXC) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The Zacks Rank for ChromaDex is 2 (Buy), suggesting a favorable outlook for the stock based on historical performance metrics [3] Performance Metrics - ChromaDex shares have increased by 68.88% over the past week, while the Zacks Medical - Biomedical and Genetics industry has declined by 0.75% during the same period [5] - Over the last quarter, CDXC shares have risen by 105.46%, and over the past year, they have gained 376.76%, significantly outperforming the S&P 500, which increased by 15.2% and 38.09% respectively [6] - The average 20-day trading volume for CDXC is 2,538,904 shares, indicating strong trading activity [7] Earnings Outlook - In the past two months, three earnings estimates for ChromaDex have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $0.01 to$0.04 [9] - For the next fiscal year, two estimates have moved up, while one has been revised down [9] - Overall, ChromaDex is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [9]